HOOK
Price
$1.34
Change
+$0.02 (+1.52%)
Updated
May 2 closing price
Capitalization
16.16M
LIMN
Price
$8.04
Change
-$2.03 (-20.16%)
Updated
May 2 closing price
Capitalization
N/A
Ad is loading...

HOOK vs LIMN

Header iconHOOK vs LIMN Comparison
Open Charts HOOK vs LIMNBanner chart's image
HOOKIPA Pharma
Price$1.34
Change+$0.02 (+1.52%)
Volume$549.69K
Capitalization16.16M
Liminatus Pharma
Price$8.04
Change-$2.03 (-20.16%)
Volume$96.55K
CapitalizationN/A
HOOK vs LIMN Comparison Chart
Loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOOK vs. LIMN commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOOK is a Hold and LIMN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (HOOK: $1.34 vs. LIMN: $8.04)
Brand notoriety: HOOK and LIMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOOK: 650% vs. LIMN: 693%
Market capitalization -- HOOK: $16.16M vs. LIMN: $0
HOOK [@Biotechnology] is valued at $16.16M. LIMN’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOOK’s FA Score shows that 1 FA rating(s) are green whileLIMN’s FA Score has 1 green FA rating(s).

  • HOOK’s FA Score: 1 green, 4 red.
  • LIMN’s FA Score: 1 green, 4 red.
According to our system of comparison, HOOK is a better buy in the long-term than LIMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOOK’s TA Score shows that 4 TA indicator(s) are bullish.

  • HOOK’s TA Score: 4 bullish, 5 bearish.

Price Growth

HOOK (@Biotechnology) experienced а +57.65% price change this week, while LIMN (@Biotechnology) price change was +50.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

HOOK is expected to report earnings on Feb 28, 2025.

LIMN is expected to report earnings on Apr 16, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIMN YTD gains are higher at: -28.342 vs. HOOK (-33.333).
HOOKLIMNHOOK / LIMN
Capitalization16.2MN/A-
EBITDA-40.85MN/A-
Gain YTD-33.333-28.342118%
P/E RatioN/AN/A-
Revenue43.9MN/A-
Total Cash39.7MN/A-
Total Debt875KN/A-
FUNDAMENTALS RATINGS
HOOK: Fundamental Ratings
HOOK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HOOK
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BUR13.970.45
+3.33%
Burford Capital Limited
CTRA25.670.78
+3.13%
Coterra Energy
CANG4.05-0.01
-0.25%
Cango
GERN1.38-0.05
-3.50%
Geron Corp
AFMD0.96-0.14
-12.73%
Affimed NV

LIMN and

Correlation & Price change

A.I.dvisor tells us that LIMN and MTVA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIMN and MTVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
-20.16%
MTVA - LIMN
31%
Poorly correlated
+2.22%
HOOK - LIMN
24%
Poorly correlated
+1.52%
TVRD - LIMN
6%
Poorly correlated
+5.03%
OSRH - LIMN
3%
Poorly correlated
+4.44%
ASBP - LIMN
1%
Poorly correlated
-5.29%
More